Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

framework programe

This project has received funding from the European Union’s Horizon 2020 Future and Emerging Technologies programme under grant agreement number 858014


vrije universiteit

Vrije Universiteit Brussel (coordinator)

universite de geneve

Université de Genève

Institute of biomedical research of A Coruña


ProtoQSAR S.L.

News and events